<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Regenerative Medicine on GiveMeTechnology</title><link>https://givemetechnology.com/tags/regenerative-medicine/</link><description>Recent content in Regenerative Medicine on GiveMeTechnology</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Sat, 14 Mar 2026 15:45:56 +0000</lastBuildDate><atom:link href="https://givemetechnology.com/tags/regenerative-medicine/index.xml" rel="self" type="application/rss+xml"/><item><title>Japan Approves World's First iPSC Cell Treatment</title><link>https://givemetechnology.com/2026/03/japan-approves-worlds-first-ipsc-cell-treatment/</link><pubDate>Sat, 14 Mar 2026 15:45:56 +0000</pubDate><guid>https://givemetechnology.com/2026/03/japan-approves-worlds-first-ipsc-cell-treatment/</guid><description>What Happened Japan&amp;rsquo;s regulatory authorities have issued the first-ever approvals for manufacturing and selling medical products based on induced pluripotent stem cell (iPSC) technology. This groundbreaking decision represents the culmination of two decades of scientific development that began when Japanese researcher Shinya Yamanaka first successfully reprogrammed adult mouse cells in 2006, work that later earned him the Nobel Prize in Physiology or Medicine.
The approved treatments utilize iPSCs—adult cells that have been genetically reprogrammed to return to an embryonic-like state while maintaining the patient&amp;rsquo;s original DNA.</description></item></channel></rss>